Ailsa Sita-Lumsden

1.8k total citations
29 papers, 861 citations indexed

About

Ailsa Sita-Lumsden is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Molecular Biology. According to data from OpenAlex, Ailsa Sita-Lumsden has authored 29 papers receiving a total of 861 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Oncology, 7 papers in Pulmonary and Respiratory Medicine and 6 papers in Molecular Biology. Recurrent topics in Ailsa Sita-Lumsden's work include COVID-19 and healthcare impacts (6 papers), MicroRNA in disease regulation (4 papers) and Ectopic Pregnancy Diagnosis and Management (4 papers). Ailsa Sita-Lumsden is often cited by papers focused on COVID-19 and healthcare impacts (6 papers), MicroRNA in disease regulation (4 papers) and Ectopic Pregnancy Diagnosis and Management (4 papers). Ailsa Sita-Lumsden collaborates with scholars based in United Kingdom, Italy and Spain. Ailsa Sita-Lumsden's co-authors include Charlotte L. Bevan, D. Alwyn Dart, Jonathan Waxman, R. Swaminathan, Heather Milburn, Philip Savage, D Short, Claire Fletcher, Greg N. Brooke and Helen Cheng and has published in prestigious journals such as Nature, Journal of Clinical Oncology and Analytical Chemistry.

In The Last Decade

Ailsa Sita-Lumsden

27 papers receiving 842 citations

Peers

Countries citing papers authored by Ailsa Sita-Lumsden

Since Specialization

Citations

This map shows the geographic impact of Ailsa Sita-Lumsden's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ailsa Sita-Lumsden with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ailsa Sita-Lumsden more than expected).

Fields of papers citing papers by Ailsa Sita-Lumsden

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ailsa Sita-Lumsden. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ailsa Sita-Lumsden. The network helps show where Ailsa Sita-Lumsden may publish in the future.

Co-authorship network of co-authors of Ailsa Sita-Lumsden

This figure shows the co-authorship network connecting the top 25 collaborators of Ailsa Sita-Lumsden. A scholar is included among the top collaborators of Ailsa Sita-Lumsden based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ailsa Sita-Lumsden. Ailsa Sita-Lumsden is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Title	Journal	Authors	Indexed citations
1	P-253 Single agent immunotherapy in advanced oesophago-gastric (OG) cancer: An option for frail patients	Annals of Oncology	Muhammad Khan, Beth Russell et al.	0
2	Natural immunity to SARS-CoV-2 and breakthrough infections in vaccinated and unvaccinated patients with cancer	British Journal of Cancer	Alessio Cortellini, Ramón Salazar et al.	5
3	Clinical effectiveness of SARS-CoV-2 vaccines and booster doses in patients with cancer: An analysis from the European OnCovid registry.	Journal of Clinical Oncology	David J. Pinato, Daniela Ferrante et al.	2
4	1588P SARS-CoV-2 antibody seroprevalence and safety of vaccines in cancer patients who recovered from COVID-19	Annals of Oncology	Meera Patel, Eudald Felip et al.	1
5	319O The systemic pro-inflammatory response identifies cancer patients with adverse outcomes from SARS-CoV-2 infection	Annals of Oncology	Gino M Dettorre, Nikolaos Diamantis et al.	3
6	Abstract P6-18-23: Palbociclib and endocrine therapy in fourth line and beyond for hormone receptor-positive HER2-negative advanced breast cancer: The UK compassionate access program experience	Cancer Research	Nicolò Matteo Luca Battisti, Belinda Kingston et al.	1
7	Palbociclib and endocrine therapy in heavily pretreated hormone receptor-positive HER2-negative advanced breast cancer: the UK Compassionate Access Programme experience	Breast Cancer Research and Treatment	Nicolò Matteo Luca Battisti, Belinda Kingston et al.	15
8	Revising the role of the androgen receptor in breast cancer	Journal of Molecular Endocrinology	Ailsa Sita-Lumsden, Charlotte L. Bevan et al.	66
9	The relationship of maternal age to molar pregnancy incidence, risks for chemotherapy and subsequent pregnancy outcome	Journal of Obstetrics and Gynaecology	Philip Savage, Ailsa Sita-Lumsden et al.	81
10	Uterine artery pulsatility index improves prediction of methotrexate resistance in women with gestational trophoblastic neoplasia with FIGO score 5–6	BJOG An International Journal of Obstetrics & Gynaecology	Ailsa Sita-Lumsden, Rosemary A. Fisher et al.	32
11	Circulating microRNAs as potential new biomarkers for prostate cancer	British Journal of Cancer	Ailsa Sita-Lumsden, D. Alwyn Dart et al.	125
12	Androgen-regulated processing of the oncomir MiR-27a, which targets Prohibitin in prostate cancer	Human Molecular Genetics	Claire Fletcher, D. Alwyn Dart et al.	124
13	Treatment outcomes for 618 women with gestational trophoblastic tumours following a molar pregnancy at the Charing Cross Hospital, 2000–2009	British Journal of Cancer	Ailsa Sita-Lumsden, D Short et al.	106
14	Advances in the treatment of pancreatic neuroendocrine tumours	QJM	Fu Gao, Ailsa Sita-Lumsden et al.	1
15	Reducing prohibitin increases histone acetylation, and promotes androgen independence in prostate tumours by increasing androgen receptor activation by adrenal androgens	Oncogene	D. Alwyn Dart, Greg N. Brooke et al.	19
16	Lymphoma in the immunocompromised	British Journal of Hospital Medicine	Ailsa Sita-Lumsden, Mark Bower et al.	2
17	No evidence for a polyomavirus association or aetiology in AIDS-associated nonsmall cell lung cancer	AIDS	Justin Stebbing, Colin Wickenden et al.	8
18	Regression of melanoma metastases following treatment with the n-bisphosphonate zoledronate and localised radiotherapy	Clinical Immunology	Ute Laggner, Juanita Lopez et al.	23
19	Reactivation of tuberculosis and vitamin D deficiency: the contribution of diet and exposure to sunlight	Thorax	Ailsa Sita-Lumsden, R. Swaminathan et al.	106
20	Sun related vitamin D deficiency and reactivation of tuberculosis	Thorax	Ailsa Sita-Lumsden, R. Swaminathan et al.	2

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact